SpaceWar.com - Your World At War
Trump unveils revised US biodefense strategy
Washington, Sept 18 (AFP) Sep 18, 2018
US President Donald Trump unveiled a new strategy Tuesday aimed at reducing the risks of man-made and naturally occurring biological threats.

The announcement came on the anniversary of the 2001 anthrax bio-terror attacks in Washington and elsewhere that killed five people.

"Biological threats emanate from many sources, and they know no borders," Trump said in a statement.

"They have great potential to disrupt the economy, exact a toll on human life, and tear at the very fabric of society."

The Trump administration last year outlined in its National Defense Strategy the need to better address a growing risk of agents, including Ebola and anthrax.

The new strategy is aimed at improving the way the government coordinates its biodefense measures and how it prepares for and responds to biological incidents.


ADVERTISEMENT




Space News from SpaceDaily.com
Private capital targets mission-critical software power and platforms in new space economy
Maven stays silent after routine pass behind Mars
Uranus and Neptune may be rock rich worlds

24/7 Energy News Coverage
IAEA calls for repair work on Chernobyl sarcophagus
South Africa's informal miners fight for their future in coal's twilight
China's smaller manufacturers look to catch the automation wave

Military Space News, Nuclear Weapons, Missile Defense
Autonomous DARPA project to expand satellite surveillance network by BAE Systems
UK's new military chief to stress Russian threat; Royal navy tracked Russian sub in Channel
Momentus joins US Space Force SHIELD contract vehicle

24/7 News Coverage
Indonesia flood death toll passes 1,000 as authorities ramp up aid
US agency wipes climate change facts from website: reports
Kennedy's health movement turns on Trump administration over pesticides



All rights reserved. Copyright Agence France-Presse. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of Agence France-Presse.